none
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Hospitalized neonates, infants and young children aged <=24 months; 2. The guardians of the research subjects can maintain good communication with the investigators, comply with the requirements of the clinical trial, and voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Those born with congenital genetic metabolic diseases; 2. Congenital abnormalities of the kidneys and urethra, including renal hypoplasia/dysplasia, posterior urethral valves and other congenital abnormalities of the kidneys and urethra; 3. Patients with cystic kidney disease; 4. Patients with congenital nephrotic syndrome; 5. Patients with bilateral renal vein thrombosis, renal artery thrombosis and renal infarction; 6. Patients with urethral stricture and indwelling catheterization dysfunction caused by traumatic bladder catheterization; 7. Diagnosed with impaired renal function due to prenatal, intrapartum infection, ischemia and other factors; 8. The investigator believes that there are any other factors that are not suitable for participating in this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Renal ultrasound;Glomerular filtration rate equation; | — |
Countries
China